Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleCLINICAL INVESTIGATIONS

Is Correction for Age Necessary in SPECT or PET of the Central Serotonin Transporter in Young, Healthy Adults?

Ralph Buchert, Oliver Schulze, Florian Wilke, Georg Berding, Rainer Thomasius, Kay Petersen, Winfried Brenner and Malte Clausen
Journal of Nuclear Medicine January 2006, 47 (1) 38-42;
Ralph Buchert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Schulze
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florian Wilke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georg Berding
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rainer Thomasius
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kay Petersen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Winfried Brenner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malte Clausen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

PET and SPECT have suggested that there is an age-related decline of up to 10% per decade in the availability of brain serotonin transporter (SERT) in healthy subjects, starting as early as the age of 20 y. The aim of the present study was to verify these findings in young subjects. Methods: The equilibrium specific-to-nonspecific partition coefficient V″3 of the SERT ligand 11C-(+)McN5652 was obtained for 29 healthy subjects aged 18–33 y. V″3 was tested for age dependence by linear regression analysis using both a volumes-of-interest approach and voxel-based statistical parametric mapping. The sex of the subject and the season of year were considered nuisance variables. Results: Age had no significant effect on V″3. The power for the detection of an age-related decline in V″3 of the magnitude reported previously was 0.917. Conclusion: These findings indicate that age is not a relevant confounding factor for SERT availability as measured by 11C-(+)McN5652 PET in healthy adults up to the age of about 35 y.

  • serotonin transporter
  • age
  • PET
  • (+)McN5652
View Full Text
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 47 (1)
Journal of Nuclear Medicine
Vol. 47, Issue 1
January 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Is Correction for Age Necessary in SPECT or PET of the Central Serotonin Transporter in Young, Healthy Adults?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Is Correction for Age Necessary in SPECT or PET of the Central Serotonin Transporter in Young, Healthy Adults?
Ralph Buchert, Oliver Schulze, Florian Wilke, Georg Berding, Rainer Thomasius, Kay Petersen, Winfried Brenner, Malte Clausen
Journal of Nuclear Medicine Jan 2006, 47 (1) 38-42;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Is Correction for Age Necessary in SPECT or PET of the Central Serotonin Transporter in Young, Healthy Adults?
Ralph Buchert, Oliver Schulze, Florian Wilke, Georg Berding, Rainer Thomasius, Kay Petersen, Winfried Brenner, Malte Clausen
Journal of Nuclear Medicine Jan 2006, 47 (1) 38-42;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • THIS MONTH IN JNM
  • PubMed
  • Google Scholar

Cited By...

  • Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire